BriaCell Therapeutics Prices $8.5M Equity Offering (NASDAQ:BCTX)
Wednesday, 11 September 2024, 17:17
Equity Offering Overview
BriaCell Therapeutics has recently announced the pricing of its latest equity offering. The company will issue 12.33 million shares at a price of $0.69 per share, aiming to raise approximately $8.5 million. These funds are crucial for advancing its pipeline projects.
Use of Proceeds
- Research and Development
- General Corporate Purposes
This influx of capital is expected to enhance BriaCell's ability to pursue new opportunities in the biotechnology landscape.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.